Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
CEOs from diverse sectors on what's in store for 2017
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat